James Cunningham BS, PhD

Dr James Cunningham is Director of Ocular Drug Delivery at Allergan, where he is responsible for early development of drug delivery-enabled dosage forms for both small and large molecules. Prior to joining Allergan in 2014, Jim held a number of increasingly senior roles at Elan Drug Technologies and Merck Research Laboratories, spanning formulation of poorly soluble drugs, small molecule parenteral formulation development, siRNA therapeutics delivery, formulation-based lifecycle management, and development of products for low-resource settings. He earned his PhD from the University of Michigan, Ann Arbor, and his BS from Cornell University, both in Chemical Engineering.